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Bone marrow-derived (B) lymphocytes are antibody-forming cell precursors 
which when appropriately activated differentiate into antibody-secreting cells. 
Activation of B lymphocytes by mitogens and certain thymic-independent  anti- 
gens is thought to occur directly without cooperation of other cells (I,  2).  In 
contrast, the antibody response to most soluble protein antigens is defective in 
the  absence  of stimulated  T  cells  (3-5).  In  addition  to  differentiation into 
antibody-secreting  cells, B cells have also been shown to be capable of producing 
the biologically active mediators (lymphokines) associated with cell-mediated 
immune responses once thought to be the exclusive function of T cells.  While B 
cells can be activated nonspecifically by B-cell mitogens and by triggering at 
their C3 and Fc surface receptors (6), investigations in our laboratory (6, 7) and 
in others (8) suggest that B cells cannot be triggered by soluble protein antigens 
to produce lymphokines. In view of the failure of B cells to differentiate into 
antibody-producing cells in the absence of T cells, we considered it likely that 
the defect in lymphokine production might be due to a requirement for T cells. 
In the present study, we have investigated the mechanism of antigen-specific 
lymphokine synthesis by  B  cells.  We  have  found  that  this  B-cell  function 
requires T-cell help and that this help is mediated by a soluble factor produced 
by antigen-activated T cells. 
Materials and Methods 
Animals and Immunization.  400-500 g  male,  Hartley guinea pigs (Buckberg Lab Animals, 
Tomkins Cove, N. Y.) were immunized with dinitrophenylated ovalbumin (DNP14-OA) 1 in com- 
plete Freund's adjuvant (CFA) (7) or with 3 ~g tetanus toxoid (T.T) (Department of Public Health, 
Boston,  Mass.)  in CFA. Spleens and/or oil-induced peritoneal exudate cells were obtained from 
these animals 2-4 wk later. Nonimmunized guinea pigs (>500 g) were used as a source of glycogen- 
induced peritoneal macrophages for chemotaxis assays. 
Separation  of T and B Lymphocytes.  T  and B  lymphocytes were separated  from single cell 
~Abbreviations  used  in this paper:  BCAF,  B-cell-activating factor;  CFA, complete Freund's 
adjuvant;  CTX,  chemotactic factor; DNP-OA,  dinitrophenylated  ovalbumin;  E,  rabbit  erythro- 
cytes;  [3H]TdR,  tritiated  thymidine;  LPS,  lipopolysaccharide;  MNL,  monocyte or macrophage; 
PELs, peritoneal exudate lymphocytes; POL, polymerized flagellin; T.T., tetanus toxoid. 
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suspensions  of the  spleens  of immunized  guinea  pigs  as  previously  described  (6).  Briefly,  T 
lymphocytes were eluted off a nylon wool column and further purified by repassage over a second 
nylon column.  B  lymphocytes  were  isolated by removing on Ficoll-Hypaque  gradients T  cells 
which had rosetted with rabbit erythrocytes (E). Repeating this procedure with the nonrosetted 
cells resulted in a  population of cells representing 10-25% of the total spleen cells which were 
>95% Ig positive (6) and responded to B, but not T, cell mitogens. Lymphocytes were suspended in 
RPMI  1640  media  (NIH  Media  Unit,  Bethesda,  Md.)  containing 2  mM  glutamine,  100  IU/ml 
penicillin, and 100 pg/ml streptomycin, but without serum and cultured as reported (6). 
Proliferation Assay.  Cultures of T and B cells were pulsed with 1 ~Ci/ml tritiated thymidine 
([SH]TdR) (sp. act 6.0 Ci/mmol; Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg, N. Y.) 
4  h  before  harvest.  The  cultures  were  harvested by  means of a  modified  Skatron automated 
harvester (Flow Laboratories, Inc., Rockville, Md.) onto glass fiber filters. The filters were placed 
in scintillation vials with 5 ml scintillation fluid for determination of incorporated ['~H]TdR in a 
Beckman Scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). Data are expressed 
as mean counts per min per culture (1  ×  10  e cells) for triplicate cultures. 
Chemotaxis Assay.  Cell-free supernates from these cultures were assayed for their ability to 
induce macrophage migration across polycarbonate (Nuclepore, Neuroprobe, Inc., Bethesda, Md.) 
filters with 5-pm pores. The chemotaxis assays were carried out in modified Boyden chambers (6). 
Triplicate filters were run for each sample and migration quantitated by counting 20 oil immer- 
sion fields per filter. Data are expressed as the mean number of cells per oil immersion field -  1 SE 
for the triplicate filters. 
Production of Supernates from T Lymphocytes.  Peritoneal exudate cells were obtained 4 days 
after injection of sterile mineral oil (Drakeol 6-VR; Penreco Inc., Butler, Pro) into the peritoneal 
cavities  of  immunized  guinea  pigs.  The  harvested  cells  were  pooled,  washed  several  times, 
suspended in warm RPMI 1640 containing 10% fetal calf serum, and applied to prewashed glass 
bead  columns  (9).  The  loaded  columns  were  incubated  45  min  at  37°C,  in  5%  CO2,  and  the 
nonadherent cells eluted with 100 ml of warm medium.  These nonadherent peritoneal exudate 
lymphocytes (PELs) which are enriched in antigen-reactive T cells (10) were washed several times 
in serum-free medium and resuspended at 1 ×  106/ml with 2 ~g/ml antigen or medium only and 
incubated for 20 h  unless otherwise indicated.  The cultures were centrifuged and the cell-free 
supernates frozen (-2O°C) until used. These supernates were added to B-lymphocyte cultures (0.5 
ml at 2  ×  106/ml)  in varying amounts and the total volume of each culture adjusted to 1 ml with 
serum-free RPMI 1640. 
Mitogens, Antigens,  and Drugs.  Antigens used in these experiments included DNP-OA and 
T.T.  Lipopolysaccharide (LPS) from Escherichia coli 055:B5, (Difco Laboratories, Detroit, Mich.) 
and polymerized flagellin (POL) prepared from Salmonella adelaide (11) were utilized as B-cell 
mitogens. Cycloheximide and actinomycin D were obtained from Sigma Chemical Co., St. Louis, 
Mo. 
Results 
T-Lymphocyte Requirement for Antigen.Induced  Lymphokine Production by 
B Cells.  B cells obtained by the selective removal of E-rosette forming T cells 
from the spleens of DNP-OA-sensitized  guinea pigs were incapable of respond- 
ing to the thymic-dependent antigen DNP-OA as measured by proliferation and 
production of a lymphokine chemotactic for macrophages (MNL CTX) (Table I). 
However, these same B cells proliferated and produced MNL CTX when stimu- 
lated with the B-cell  mitogens,  LPS and POL (Table I).  Previous studies have 
shown that addition of macrophages does not enable B cells to respond to DNP- 
OA (7), however,  a B-cell  response could require T cells.  In order to determine 
whether the B cells could be induced to respond to DNP-OA in the presence of T 
cells, the purified B lymphocytes were reconstituted with increasing numbers of 
DNP-OA-primed T cells. As seen in Fig. 1, B cells alone did not respond to DNP- 
OA, but when reconstituted with as few as 10% T cells a significant amount of 
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TABLE  I 
Proliferation and Lymphokine Production by B Cells in Response 
to Mitogens and Antigens 
Stimulant  [3H]TdR incorpora-  Chemotactic ac- 
tion (E/C)  tivity 
None*  1.05  9  -+ 3 
DNP-OA  1.1  3  _+  1 
LPS  3.5  69  -+ 4 
POL  7.1  87  _+ 4 
* 1 ×  106 B lymphoeytes/ml  serum-free medium were cultured with 0.1 
ml medium only, 2 ~g/ml DNP-OA, 10 /~g/ml LPS, or POL for 48 h. 
The cell-flee supernates were then assayed for chemotactie activity 
(mean number of macrophages per  oil  immersion field  _+  1  SE  of 
triplicate filters). 
$ Parallel cultures were pulsed with 1 ~tCi  [3H]TdR 4 h  before harvest 
at 48 h and assayed for incorporation of [3H]TdR.  Ratio of mean counts 
per minute of experimental to control cultures (E/C) is shown. 
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FIG.  1.  Production of MNL CTX by B cells in the presence of T cells. Chemotactic activity 
measured in 48-h supernates of cultures containing a total of 1 ×  10  e B and/or T lymphocytes 
in a vol of I ml medium. Increasing numbers of T cells were added to decreasing numbers of 
B cells and these cultures were stimulated with 2 ~g/ml DNP-OA or with medium only. 
with coincident decrease in total B cells resulted in little enhancement of MNL 
CTX.  T  cells alone did not respond to DNP-OA  due to the  absence of macro- 
phages in these preparations (Fig.  1) (7). 
Replacement of T  Cells  by a Cell-Free Supernate from Antigen-Activated T 
Cells.  Although suggestive that in the presence of small numbers of T  cells 
(10%), the B cells were producing MNL CTX, it could not be excluded that the T 
cells themselves were responsible for production of the MNL CTX found in these 
cultures.  However, if the T  cells were triggering B cells to undergo mediator 
synthesis, this might be accomplished by a T-cell product capable of interacting 
with B cells in the presence of antigen. To test this possibility a  population of 1178  ROLE  OF  B  LYMPHOCYTES  IN  CELL-MEDIATED  IMMUNITY 
highly enriched sensitized T cells (PELs) containing macrophages were cultured 
with or without DNP-OA for 20 h.  The cell-free supernates from these short- 
term  cultures  were  then  added  at  varying  concentrations  to  B  cells  in  the 
presence of 2 tLg/ml  DNP-OA. After 48 h  incubation of the B cells under these 
conditions,  the  supernates  of the  B  cells  were  assayed  for  the  presence  of 
chemotactic activity. Identical cultures were prepared of the varying concentra- 
tions of PEL supernates but in the absence of B cells to assess the chemotactic 
activity produced by the T cells during the 20 h culture period. As is evident in 
Fig.  2,  the addition  of supernates  from DNP-OA-activated PELs to the B-cell 
cultures  resulted  in  significant  levels of MNL CTX in  the  B-cell cultures  as 
compared to the chemotactic activity found in the PEL supernates alone.  Dilu- 
tion of the T-cell supernate to 1:20 still resulted in significant activation of the B 
lymphocytes. Moreover, the supernates of nonstimulated T cells were unable to 
induce B-cell production of the chemotactic lymphokine.  These data suggested 
that the antigen-stimulated  T cells were producing a soluble mediator with the 
ability to stimulate  B-cell lymphokine  synthesis in the presence of additional 
antigen. 
Specificity of the T-Cell Factor for B  Cells.  Supernates from antigen-stimu- 
lated  PELs were added  to  B  cells and  to T  cells with  DNP-OA to determine 
whether the T-cell factor(s) could induce mediator synthesis by T cells as well as 
B cells.  Whereas B cells cultured in varying concentrations of the T-cell factor 
produced  highly  significant  levels of MNL  CTX,  the  macrophage-depleted  T 
cells incubated with identical concentrations of the factor were not activated to 
produce MNL CTX (Fig. 3). Rather, loss of inherent chemotactic activity in the 
PEL supernates occurred when added to T-cell cultures.  Thus it appeared that 
the factor(s) produced by antigen-activated  T cells was B-cell specific. 
Kinetics of Production of the B-Cell Activating Factor (BCAF).  PEL cul- 
tures  were established  with  and  without  antigen  and  incubated  for varying 
times from 1 to 48 h. At each interval the supernates were harvested and frozen 
until  the  final  cultures  were terminated.  These  T-cell  supernates  were then 
added to B-cell cultures and to cultures lacking B cells for 48 h. The supernates 
from these secondary B-cell cultures were then assayed for chemotactic activity. 
After 1 h  incubation of both antigen-stimulated  and nonstimulated  PELs their 
supernates were consistently capable of inducing significant levels of mediator 
production  by the  B  cells  (Fig.  4)  as  compared  to  the  levels  of chemotactic 
activity found in the supernates alone. A decline in BCAF activity from 4-h PEL 
supernates  followed by a  rise  in  the  BCAF  of supernates  from  8-h  antigen- 
exposed T cells, but not in nonstimulated T-cell cultures, suggested an antigen- 
induced synthesis of this T-cell factor which activated B cells. The stimulated 
cells produced high  levels of BCAF peaking at about 20 h  with no significant 
increase  at later intervals.  In contrast,  nonantigen-stimulated  T  cells did not 
demonstrate release of BCAF during the 48 h period with the exception of the 1st 
h  culture  supernates.  Furthermore,  the  intrinsic  chemotactic  activity  of an 
equivalent  amount  of antigen-stimulated  PEL supernate  was low at 8 h  and 
because it was diluted when added to the B cells showed only a slight increase 
during the 48 h  culture period. 
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FIG. 2.  Production of MNL CTX by B cells in the presence ofT-cell supernate. Chemotactic 
activity measured in the 48-h supernates (Sups) of B  cells which had been cultured with 
DNP-OA-activated PEL supernates or nonstimulated PEL supernates. Additionally, the 
PEL supernates were diluted and cultured under identical conditions without B cells as a 
control assay for PEL-produced chemotactic activity. All cultures received 2 /~g/ml DNP- 
OA.  Data are presented as the mean of triplicate samples with standard errors less than 
10% of the mean. 
Production.  Experiments were initiated to determine whether the BCAF was 
antigen specific or a nonspecific factor capable of triggering the B cells. Super- 
nates were prepared  from DNP-OA-stimulated PELs of DNP-OA-immunized 
guinea pigs and also from T.T.-stimulated PELs of T.T.-immunized animals. 
These supernates were then added along with the appropriate antigen or the 
nonspecific antigen to sensitized B-cell cultures. Addition of DNP-OA plus DNP- 
OA PEL supernates to DNP-OA-sensitized B cells resulted in marked produc- 
tion of MNL CTX by the B cells as, already described and as shown in Fig. 5. 
Similarly, DNP-OA plus supernates from T.T.-stimulated T cells when added to 
DNP-OA-sensitized B  cells also resulted in production of MNL CTX by the B 
cells. It does not appear necessary for the T  cells to be triggered by the same 
antigen as the B cells since T. T, -activated T  cells produce a  factor capable of 1180  ROLE  OF  B  LYMPHOCYTES  IN  CELL-MEDIATED  IMMUNITY 
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FIG.  3.  Specificity of the T-cell factor for B cells. Supernates from DNP-OA-stimulated 
PELs were added in varying dilutions (1:2.5-1:10)  to 1 ×  106 B cells or T cells from spleens. 
The same dilutions were incubated in the absence of cells. The 48-h supernates from these 
cultures were assayed for chemotactic activity. 
stimulating  DNP-OA-sensitized B cells.  A  requirement  for specific antigen  in 
addition to BCAF, however, was demonstrated since DNP-OA-sensitized B cells 
were not activated in the absence of DNP-OA. T.T. in concert with T.T.-induced 
PEL supernates was not sufficient to trigger DNP-OA sensitized B cells (Fig. 5, 
left panel) although the same supernates in the presence of DNP-OA did trigger 
B-cell mediator production. Identical results were obtained when T.T.-sensitized 
B cells were used as the test population (Fig. 5, right panel). T.T. in combination 
with supernates from either DNP-OA- or T.T.-induced PELs resulted in B-cell 
triggering.  Thus in this system, specificity resides in both the T cell and the B 
cell, in that each cell must be triggered by the appropriate  antigen.  However, 
the T-cell factor is nonantigen  specific in its action on the B lymphocyte. 
Kinetics  of  BCAF  Antigen-Induced  Release  of  MNL  CTX  by  B 
Cells.  Addition  of BCAF  from  20  h  T-cell  cultures  and  antigen  to  B  cells 
resulted  in  lymphokine  production  consistent  with  the  kinetics  of a  cellular 
immune response. Significant MNL CTX activity above controls in these B-cell 
cultures was observed at 12 h after the addition of antigen and BCAF (Fig. 6). 
BCAF-induced  B-cell  activation  continued  to  increase  from  12  h  to  48-72  h, 
declining thereafter. 
Proliferation  of B  Cells Induced  by BCAF.  In  parallel  cultures  to  those A  ,,i 
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Fro.  4.  Kinetics  of BCAF  production.  Chemotactic  activity  in  48-h  B-cell  supernates 
(Sups) which were cultured with antigen and 1- to 48-h supernates (1:2.5) from DNP-OA and 
nonstimulated PELs. DNP-OA PEL supernates (1:2.5) were also cultured without B cells to 
determine intrinsic T-cell-derived MNL CTX. 
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FIG.  5.  Requirement  for  BCAF and  specific antigen  in  B-cell activation.  Chemotactic 
activity in 48-h supernates for B cells stimulated with specific or nor,  specific antigen and 
BCAF. Left panel: DNP-OA-sensitized B cells incubated with DNP-OA or T.T. and DNP- 
OA-stimulated supernates  (Sups)  from DNP-OA-sensitized T  cells or T.T.-stimulated su- 
pernates from T.T.-sensitized T cells. Right panel: T.T.-sensitized B cells incubated with 
the  same  combinations  of antigen and  T-cell supernates  as  indicated  for the  DNP-OA- 
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FIG.  6.  Kinetics of B-cell production of MNL CTX. B cells were incubated with DNP-OA 
and antigen-stimulated or nonstimulated T-cell (PEL) supernates (Sup) for various inter- 
vals from 12 to 96 h. The cell-free supernates from the B-cell cultures were then assayed for 
chemotactic activity (mean of triplicate experiments with SE less than 10% of mean). 
established for analysis of the kinetics of B-cell MNL CTX production triggered 
by BCAF and antigen, the degree of [SH]TdR incorporated by the B cells under 
these conditions was also assessed (Fig.  7).  High background incorporation of 
[3H]TdR  was recorded at 24 h, precluding detection of significant elevation of 
proliferation by BCAF.  However, by 48 h,  nonstimulated cultures had little 
incorporation of [3H]TdR,  while cultures stimulated with BCAF and DNP-OA 
had elevated levels of proliferation. By 72-96 h  in these serum-free cultures, 
blastogenic responses were subsiding. Thus, in addition to triggering B cells to 
synthesize lymphokines, the T-cell factor(s) also induced a  B-cell proliferative 
response to this T-dependent antigen. 
Discussion 
The inability of isolated populations of sensitized B cells to produce lympho- 
kines when stimulated with DNP-OA and the restoration of this function with 
small numbers of T cells is suggestive that B-cell triggering by antigen is T-cell 
dependent. While it has been reported that B cells alone can produce lympho- 
kines in response to  antigen  (12), our studies indicat~ a  T-cell requirement. 
These findings are consistent with the recent report of Bloom and Shevach (8) in S.  M.  WAHL  AND  D.  L.  ROSENSTREICH  1183 
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FIG.  7.  Kinetics  of  B-cell  proliferation  induced  by  BCAF  and  antigen.  B  cells  were 
incubated with DNP-OA and antigen-stimulated T-cell (PEL) supernate (Sup) or no super- 
nate for 24-96  h.  The cultures  were pulsed 4  h  before harvest with  1  pCi  [3H]TdR  and 
assayed for incorporation of [3H]TdR in triplicate (mean of triplicate cultures with SE less 
than 10% of mean). 
which migration  inhibition factor was not produced by either T  or B  lympho- 
cytes in a mixed population when nonresponsiveness to an antigen was a T-cell 
defect,  suggesting  a  T-cell dependence for B-cell lymphokine  synthesis.  How- 
ever,  since unseparated  populations  of spleen cells  were used it  was unclear 
whether the B cells were triggered to produce migration  inhibitory factor even 
in the responder strain bearing functional T cells. Similarly, in the T- and B-cell 
mixing experiments reported here, the data is not conclusive that the T cells are 
inducing  B-cell  mediator  production  in  response  to  DNP-OA.  It  is  possible, 
although  unlikely,  that  these  low levels of T  cells and  not the  B  cells  were 
responsible for the MNL CTX found in the supernates. Therefore, our attention 
was focused on the possible identification  of a  biologically active substance(s) 
derived from T  cells which  could enhance  or regulate  B-lymphocyte function 
subsequent to exposure to antigen as measured by lymphokine production in an 
in vitro system of cell-mediated immunity. Since intact T cells could be replaced 
by supernates of DNP-OA-stimulated T cells, T-B-cell contact did not appear to 
be essential for B-cell triggering.  Furthermore, this demonstrated that the MNL 
CTX was indeed a B-cell product and that the T-cell help could be mediated by a 
soluble factor.  The absence of BCAF in the supernates  of nonstimulated  20 h 
PEL  cultures  indicated  that  the  production  of BCAF  was  antigen  specific, 
requiring activation of the T cells for its elaboration. This is consistent with the 
inhibition  of BCAF production  by the  protein  synthesis  inhibitor,  cyclohexi- 1184  ROLE  OF  B  LYMPHOCYTES  IN  CELL-MEDIATED  IMMUNITY 
mide,  and  by actinomycin  (data  not shown).  Although  some  MNL CTX  was 
produced by the antigen-activated  T  cells and  was therefore present  in these 
secondary supernates, the T-cell factor responsible for triggering B cells could be 
readily separated from T-cell-produced MNL CTX by molecular weight, -~ indi- 
cating a  distinct mediator of B-cell reactivity. Also when added to pure T cells, 
the PEL supernate factor did not stimulate these cells to produce lymphokines. 
Specifically activated T lymphocytes then release a factor(s) that can trigger 
B-cell lymphokine production. The factor released from either T.T.- or DNP-OA- 
sensitized T cells by the appropriate antigen could stimulate DNP-OA-sensitized 
B  cells  in  the  presence  of DNP-OA  to  undergo  lymphokine  synthesis  and 
proliferation. Similarly, either T-cell factor would trigger T.T.-sensitized B cells 
provided  T.T.  was  available  to  the  B  cells  in  addition  to  the  T-cell  factor. 
Although the T-cell factor is nonspecific in its action, specificity occurs both at 
the  level  of the  T  cell  and  at  the  B  cell.  Apparently,  the  nonspecific  T-cell 
product can synergize in some fashion with the antigen to trigger B cells and the 
specificity of the  response  is ensured  since the  mediator  will only effectively 
trigger those B cells which are responding to specific antigen.  It appears then 
that two signals are required for B-cell participation  in cellular immune phe- 
nomena. The first signal is a consequence of the interaction of antigen and B-cell 
receptor, with the second signal being the nonspecific T-cell mediator. The B-cell 
encounter with antigen is not sufficient to trigger a response, but the antigen is 
converted to an inductive signal by means of BCAF which can replace T  cells 
themselves. 
How this BCAF with the potential to recruit B cells into active participants of 
a cell-mediated reaction relates to the numerous T-cell factors (13-17) described 
for  activating  B  cells  to  undergo  antibody  synthesis  in  response  to  thymic- 
dependent  antigens  is unclear.  Both nonantigen-specific  (13-16) and  antigen- 
specific (16,  17) T-cell helper factors have been identified which enable T-B-cell 
collaboration  in  humoral  immune  responses.  Recent  evidence  in  the  mouse 
suggests that the T-cell mediator in antibody production may be a  cell surface 
antigen coded for in the Ia region of the H-2 locus which binds to a homologous 
acceptor site on B-cell membranes  (18,  19), thus requiring compatible T  and B 
cells. Whether the B-cell receptor is related to Ia antigen and whether the T-cell 
product which functions to enable T-B-cell collaboration in cellular immunity is 
identical or distinct from the factors described in humoral responses is presently 
being investigated. 
However, in contrast to the antibody response which requires 4-5 days for T- 
cell-mediated B-lymphocyte differentiation culminating in antibody production, 
the B-cell response in this cell-mediated system resulting in lymphokine produc- 
tion is of much shorter duration, peaking by 48 h. Possibly, lymphokine synthe- 
sis is an early response of the B cells, occurring before B-cell differentiation and 
thus controlled by an early inductive T-cell stimulus (20), whereas a late-acting 
T-cell component (15) effective after 48 h may be responsible for B-cell differen- 
tiation  into  antibody-secreting  cells.  Multiple  factors may be involved in the 
control of the total B-cell response.  Perhaps different T-cell-derived mediators 
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are responsible for the  diverse responses of the  B  lymphocyte including  lym- 
phokine production, proliferation, and antibody secretion. Alternatively, B cells 
may  respond  differently  at  different  stages  of their  life  history  (21).  A  less 
mature B cell may be one involved in lymphokine production and therefore in 
cellular immune reactions rather than a  more mature cell which may differen- 
tiate  into  an  antibody-producing  cell.  Whether  subpopulations  of B  cells  are 
responsible for lymphokine synthesis and involvement in cell-mediated immu- 
nity  and  for antibody production  cannot be determined  at this  stage.  Such  a 
distinction might serve as a possible explanation for the different responses of B 
cells. At any rate, since the fundamental function ofT cells is cellular immunity 
and since nonspecific lymphokines  are instrumental  in  many T-cell-mediated 
responses it is reasonable that  similar  nonspecific factors influence B-cell re- 
sponsiveness not only in humoral but also in cellular immune responses. 
It thus appears that B cells may play an important function in cell-mediated 
reactions.  On recognizing antigen,  T cells release soluble lymphokines, among 
them BCAF with which B cells must interact in addition to their own recogni- 
tion of antigen.  Upon interaction of both BCAF and an antigen with the B cells, 
these cells respond by proliferating and elaborating MNL CTX and presumably 
other  lymphokines  associated  with  cell-mediated  phenomena.  The  T-cell  re- 
sponse occurs early after antigen  contact, thereby effecting a  recruitment  of B 
cells into a cell-mediated reaction in the early stages resulting in amplification 
of the response.  Indeed, Turk  and Parker  (22) have shown that cyclophospha- 
mide-treated animals which are B-cell depleted have diminished delayed hyper- 
sensitivity responses to OA.  Thus,  cell-mediated reactions which were consid- 
ered a  T-cell function may only be T-cell dependent,  but a  function of both T 
lymphocytes and B lymphocytes. The BCAF produced by antigen-stimulated  T 
cells  may  provide  the  major  pathway  for  recruitment  of B  cells  into  cell- 
mediated immune reactions. 
Summary 
Although B lymphocytes can be triggered by B-cell mitogens and by certain 
other molecules to produce tymphokines, they do not produce lymphokines when 
stimulated with specific soluble protein antigens.  We have investigated whether 
T-cell  help  would  enable  B  cells  to  produce lymphokines  when  activated  by 
antigens.  Addition  of small  numbers  of T  cells to B-cell cultures  resulted  in 
significant production of a monocyte chemotactic factor. T cells could be replaced 
by supernates of antigen-stimulated T cells, demonstrating both that the chemo- 
tactic factor was B-cell-derived and that T-cell help was mediated by a  soluble 
factor.  Although  the  T-cell  factor  was  nonantigen  specific,  B-cell  activation 
required the presence of both antigen  and T-cell factor.  Thus,  it appears that 
although dependent upon T cells, B lymphocytes may play an important role in 
amplification of cell-mediated immune responses. 
Received for publication 24 May 1976. 
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